1. United States Pharmacopeia and National Formulary (USP 41-NF 36). Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use. United States Pharmacopeial Convention; 2018. pp. 7297–7298.
2. Charnock C. The microbial content of non-sterile pharmaceuticals distributed in Norway. J Hosp Infect. 2004;57:233–40.
3. Ratajczak M, Kubicka MM, Kamińska D, et al. Microbiological quality of non-sterile pharmaceutical products. Saudi Pharm J. 2015;23(3):303–7.
4. United States Pharmacopeia and National Formulary (USP 41-NF 36). Bioburden control of nonsterile drug substances and products. United States Pharmacopeial Convention; 2018. pp. 7305–7312.
5. Sutton S, Jimenez L. A review of reported recalls involving microbiological control 2004–2011 with emphasis on FDA considerations of “objectionable organisms.” Am Pharm Rev. 2012;15(1):42–57.